STOCK TITAN

[Form 4] UNITEDHEALTH GROUP INC Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4

Timothy J. Noel, Chief Executive Officer, UHC, reported a non-derivative acquisition of common stock for UNITEDHEALTH GROUP INC (UNH) dated 09/23/2025. The transaction is coded A and is described as dividend equivalents paid on outstanding restricted stock units, which follow the same vesting terms as the underlying RSUs and are forfeited if the RSUs do not vest. The filing records a $0 price for the acquisition and shows 9,286.339 shares beneficially owned following the reported transaction(s). The form was signed by an attorney-in-fact on behalf of Mr. Noel on 09/25/2025.

Timothy J. Noel, Chief Executive Officer di UHC, ha riportato un'acquisizione non derivativa di azioni ordinarie per UNITEDHEALTH GROUP INC (UNH) datata 23/09/2025. La transazione è codificata A e descritta come dividendi equivalenti pagati su azioni restrittive in circolazione, che seguono gli stessi termini di vesting delle RSU sottostanti e vengono perse se le RSU non vestono. Il filing registra un prezzo di $0 per l'acquisizione e mostra 9,286.339 azioni beneficiariamente possedute dopo le transazioni riportate. Il modulo è stato firmato da un procuratore in fact per conto del signor Noel il 25/09/2025.

Timothy J. Noel, director ejecutivo de UHC, reportó una adquisición no derivativa de acciones comunes para UNITEDHEALTH GROUP INC (UNH) con fecha 23/09/2025. La transacción está codificada como A y se describe como equivalentes de dividendos pagados sobre acciones restringidas en circulación, que siguen los mismos términos de vesting que las RSU subyacentes y se pierden si las RSU no se consolidan. El registro indica un precio de $0 para la adquisición y muestra 9,286.339 acciones beneficiosamente poseídas tras las transacciones reportadas. El formulario fue firmado por un apoderado en nombre del Sr. Noel el 25/09/2025.

Timothy J. Noel, UHC의 CEO는 보통주의 비유래적 취득을 UNITEDHEALTH GROUP INC (UNH)에 대해 2025-09-23로 보고했습니다. 거래의 코드가 A이고 발행 주식에 대한 배당 대체금으로 설명되며, 이는 기초 RSU의 동일한 vesting 조건을 따르고 RSU가 귀속되지 않으면 몰수됩니다. 제출서류는 취득 가격을 $0으로 기록하고 보고된 거래 이후 9,286.339 주의 유익한 소유를 보여줍니다. 이 양식은 Noel 씨를 대신해 대리인이 2025-09-25에 서명했습니다.

Timothy J. Noel, directeur général d'UHC, a rapporté une acquisition non dérivée d'actions ordinaires pour UNITEDHEALTH GROUP INC (UNH) datée du 23/09/2025. La transaction est codée A et décrite comme des équivalents de dividendes versés sur les actions restreintes en circulation, qui suivent les mêmes conditions de vesting que les RSU sous-jacentes et sont perdues si les RSU ne vestent pas. Le dossier indique un prix de $0 pour l'acquisition et montre 9 286,339 actions détenues bénéficiaires après les transactions rapportées. Le formulaire a été signé par un mandataire au nom de M. Noel le 25/09/2025.

Timothy J. Noel, Chief Executive Officer von UHC, meldete eine nicht derivierte Übernahme von Stammaktien von UNITEDHEALTH GROUP INC (UNH) datiert auf den 23.09.2025. Die Transaktion ist mit dem Code A versehen und wird als Dividendenequivalente gezahlt auf ausgegebene Restricted Stock Units beschrieben, die denselben Vesting-Terms wie die zugrunde liegenden RSUs folgen und verfallen, wenn die RSUs nicht vesten. Die Einreichung verzeichnet einen $0-Preis für die Übernahme und zeigt 9.286,339 als wirtschaftlich berechtigte Aktien nach der gemeldeten Transaktion. Das Formular wurde von einem Bevollmächtigten im Namen von Herrn Noel am 25.09.2025 unterzeichnet.

تيموثي ج. نويل، الرئيس التنفيذي لـ UHC، أبلغ عن استحواذ غير مشتق على أسهم عادية لشركة UNITEDHEALTH GROUP INC (UNH) بتاريخ 23/09/2025. تم ترميز الصفقة بـ A وتوصف بأنها بدلات توزيعات مدفوعة على الأسهم المقيدة القائمة، التي تتبع نفس شروط الاستحقاق مثل RSU الأساسية وتُلغى إذا لم تستحق RSU. تسجل القاعدة سعر $0 للاستحواذ وتظهر 9,286.339 سهماً مستفاداً يمتلكها الشخص المفوض بعد المعاملات المذكورة. وقد قام محامٍ نيابةً عن السيد نويل بتوقيع النموذج في 25/09/2025.

Timothy J. Noel,UHC 的首席执行官,报告了对 UNITEDHEALTH GROUP INC(UNH)的普通股非派生收购,日期为2025-09-23。该交易的代码为A,描述为对已流通的受限股票单位的股息等价物,其归属条件同于基础 RSU,若 RSU 未归属则予以没收。该申报表将收购价格记为 $0,并显示在报告交易后拥有的受益股数为9,286.339 股。表格由代表诺尔先生的代理律师在2025-09-25签署。

Positive
  • Disclosure compliance: Form 4 filed and signed, providing transparency on insider holdings
  • Non-cash issuance clarity: Transaction explicitly described as dividend equivalents on RSUs, clarifying nature of acquisition
  • No cash outlay: Reported price of $0 indicates issuance rather than a purchase that would affect market liquidity
Negative
  • None.

Insights

TL;DR: Routine insider acquisition from dividend equivalents on RSUs; no cash purchase and modest change in beneficial holdings.

This Form 4 discloses a non-cash acquisition coded A, indicating dividend equivalents credited on outstanding restricted stock units rather than an open-market purchase. The reported price is $0 and the filing lists 9,286.339 shares owned after the transaction. For investors this is a standard equity compensation flow and does not reflect a funded buy or sale that would alter float materially.

TL;DR: Compensation-related issuance reported properly; consistent with executive RSU programs and standard disclosure practice.

The disclosure specifically states the acquisition represents dividend equivalents subject to the same vesting terms as the underlying restricted stock units, which aligns with common executive compensation designs. The filing is signed by an attorney-in-fact and appears procedural rather than signaling a change in insider intent or control.

Timothy J. Noel, Chief Executive Officer di UHC, ha riportato un'acquisizione non derivativa di azioni ordinarie per UNITEDHEALTH GROUP INC (UNH) datata 23/09/2025. La transazione è codificata A e descritta come dividendi equivalenti pagati su azioni restrittive in circolazione, che seguono gli stessi termini di vesting delle RSU sottostanti e vengono perse se le RSU non vestono. Il filing registra un prezzo di $0 per l'acquisizione e mostra 9,286.339 azioni beneficiariamente possedute dopo le transazioni riportate. Il modulo è stato firmato da un procuratore in fact per conto del signor Noel il 25/09/2025.

Timothy J. Noel, director ejecutivo de UHC, reportó una adquisición no derivativa de acciones comunes para UNITEDHEALTH GROUP INC (UNH) con fecha 23/09/2025. La transacción está codificada como A y se describe como equivalentes de dividendos pagados sobre acciones restringidas en circulación, que siguen los mismos términos de vesting que las RSU subyacentes y se pierden si las RSU no se consolidan. El registro indica un precio de $0 para la adquisición y muestra 9,286.339 acciones beneficiosamente poseídas tras las transacciones reportadas. El formulario fue firmado por un apoderado en nombre del Sr. Noel el 25/09/2025.

Timothy J. Noel, UHC의 CEO는 보통주의 비유래적 취득을 UNITEDHEALTH GROUP INC (UNH)에 대해 2025-09-23로 보고했습니다. 거래의 코드가 A이고 발행 주식에 대한 배당 대체금으로 설명되며, 이는 기초 RSU의 동일한 vesting 조건을 따르고 RSU가 귀속되지 않으면 몰수됩니다. 제출서류는 취득 가격을 $0으로 기록하고 보고된 거래 이후 9,286.339 주의 유익한 소유를 보여줍니다. 이 양식은 Noel 씨를 대신해 대리인이 2025-09-25에 서명했습니다.

Timothy J. Noel, directeur général d'UHC, a rapporté une acquisition non dérivée d'actions ordinaires pour UNITEDHEALTH GROUP INC (UNH) datée du 23/09/2025. La transaction est codée A et décrite comme des équivalents de dividendes versés sur les actions restreintes en circulation, qui suivent les mêmes conditions de vesting que les RSU sous-jacentes et sont perdues si les RSU ne vestent pas. Le dossier indique un prix de $0 pour l'acquisition et montre 9 286,339 actions détenues bénéficiaires après les transactions rapportées. Le formulaire a été signé par un mandataire au nom de M. Noel le 25/09/2025.

Timothy J. Noel, Chief Executive Officer von UHC, meldete eine nicht derivierte Übernahme von Stammaktien von UNITEDHEALTH GROUP INC (UNH) datiert auf den 23.09.2025. Die Transaktion ist mit dem Code A versehen und wird als Dividendenequivalente gezahlt auf ausgegebene Restricted Stock Units beschrieben, die denselben Vesting-Terms wie die zugrunde liegenden RSUs folgen und verfallen, wenn die RSUs nicht vesten. Die Einreichung verzeichnet einen $0-Preis für die Übernahme und zeigt 9.286,339 als wirtschaftlich berechtigte Aktien nach der gemeldeten Transaktion. Das Formular wurde von einem Bevollmächtigten im Namen von Herrn Noel am 25.09.2025 unterzeichnet.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
1. Name and Address of Reporting Person*
Noel Timothy John

(Last) (First) (Middle)
C/O UNITEDHEALTH GROUP INCORPORATED
1 HEALTH DRIVE

(Street)
EDEN PRAIRIE MN 55344

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
UNITEDHEALTH GROUP INC [ UNH ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
Chief Executive Officer, UHC
3. Date of Earliest Transaction (Month/Day/Year)
09/23/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 09/23/2025 A 42.34(1) A $0 9,286.339 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. Represents dividend equivalents paid on outstanding restricted stock units. The dividend equivalents are subject to the same terms as the underlying restricted stock units and are forfeited if such units do not vest.
Remarks:
Faraz A. Choudhry, Attorney-in-Fact for Timothy J. Noel 09/25/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Timothy J. Noel report on the UNH Form 4?

He reported a non-derivative acquisition of common stock on 09/23/2025 representing dividend equivalents on restricted stock units.

Was cash used to acquire the shares reported in the UNH Form 4?

No. The filing shows a reported price of $0, indicating the shares were credited as dividend equivalents rather than purchased with cash.

How many shares does the Form 4 show after the transaction for UNH?

The Form 4 lists 9,286.339 shares beneficially owned following the reported transaction(s).

When was the Form 4 signed for the UNH filing?

The signature, by an attorney-in-fact for Timothy J. Noel, is dated 09/25/2025.

What does transaction code 'A' mean on this UNH Form 4?

In this filing the code A is used for an acquisition and is explicitly described as dividend equivalents paid on outstanding restricted stock units.
Unitedhealth Gp

NYSE:UNH

UNH Rankings

UNH Latest News

UNH Latest SEC Filings

UNH Stock Data

312.96B
897.88M
0.82%
86.64%
1.32%
Healthcare Plans
Hospital & Medical Service Plans
Link
United States
EDEN PRAIRIE